dorsaVi (ASX:DVL) launched a 3D motion analysis test to reduce anterior cruciate ligament (ACL) injuries in athletes using its wearable sensor technology, according to a Tuesday filing with the Australian bourse.
The test uses over 10,000 proprietary knee assessments and artificial intelligence to identify unique movement patterns linked to ACL injury risk, the filing said.
Shares rose nearly 13% in morning trade Wednesday.
Price (AUD): $0.01, Change: $+0.00100, Percent Change: +12.50%